Regenxbio Inc (RGNX)

R&D Expense Growth

-2.19%

Quarterly · Period ending:

RGNX logo

RGNX R&D Expense Growth

Latest reported-2.19%
RGNX Quarterly R&D Growth (QoQ) (0.00% → -2.19%)
High-resolution chart · PNG

RGNX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-2.1852%
-3.8114%
6.2566%
0.9102%
4.7243%
5.3732%
-7.439%
21.4445%
-11.5388%
-1.3282%
-11.7509%
-2.8437%
2.3412%
-6.3819%
-1.2762%
3.7782%
9.6734%
15.9427%
0.257%
4.3002%
15.5078%
-15.8075%
7.3053%
15.3683%
2.9054%
9.5483%
-5.2813%
21.0596%
16.9821%
3.5924%
31.4513%
-13.8602%
9.9028%
37.9675%
13.197%
-10.0525%
-16.2585%
3.4871%
27.8583%
17.603%
72.7317%
28.4913%
-15.0424%
41.1765%
43.7478%
33.413%
92.8111%
27.6471%
-9.285%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.